Striving for a Cure for Pediatric Cancers
According to the American Cancer Society, pediatric cancers are different than what normally develops in adults. They include Acute Lymphocytic Leukemia (ALL), Non-Hodgkin Lymphoma (NHL), Hodgkin Lymphoma (HL), and Acute Myeloid Leukemia (AML). Brain tumors and unique solid tumors such as Neuroblastoma, Wilms Tumor and sarcomas are also common.
"PCF has been instrumental in providing critical grant support over the past quarter of a century to help raise the cure rate in pediatric cancer from approximately 50-60 percent to 85-90 percent today," says Dr. Mitchell S. Cairo, professor of pediatrics, medicine, pathology, microbiology and immunology, and cell biology and anatomy and New York Medical College and chief of pediatric hematology, oncology and stem cell transplantation at Maria Fareri Children's Hospital.
NYMC faculty: Mitchell S. Cairo, M.D., professor of pediatrics, medicine, pathology, microbiology and immunology, and cell biology and anatomy